JOHN HARRIS: Open Payments
NPI 1871518860 · RINGGOLD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 41 payments from 17 companies in 2025. Trend: 2023 $734 · 2024 $782 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $114 |
| Lilly USA, LLC | 5 | $101 |
| ABBVIE INC. | 4 | $91 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| Sumitomo Pharma America, Inc. | 3 | $66 |
| SHIELD THERAPEUTICS INC | 3 | $64 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| Dexcom, Inc. | 2 | $50 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Exact Sciences Corporation | 2 | $34 |
Products named: VRAYLAR, GEMTESA, ACCRUFER, MOUNJARO, LEQVIO, Dexcom G6 Transmitter, JARDIANCE, ELIQUIS.
Industry payments across GA — which companies pay providers there.
